Experimental Physiology
	

Celebrating 100 years
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Physiology in Press

First published online on February 29, 2008.
Experimental Physiology (2008)
DOI: 10.1113/expphysiol.2007.041657
© The Physiological Society 2008

A more recent version of this article appeared on May 1, 2008
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
93/5/676    most recent
expphysiol.2007.041657v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, Z.
Right arrow Articles by Morris, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, Z.
Right arrow Articles by Morris, M.

Received December 3, 2007
Revised January 3, 2008
Accepted after revision February 25, 2008


Cardiovascular Control [210]

RNA interference shows interactions between brainstem angiotensin AT1 receptors and ACE2

Zhanyi Lin 1, Yanfang Chen 2, Wenfeng Zhang 2, Alex F. Chen 3, Shuguang Lin 1, Mariana Morris 2*

1 Guangdong Cardiovascular Institute
2 Wright State University, Boonshoft School of Medicine
3 Michigan State University School of Medicie

* To whom correspondence should be addressed. E-mail: mariana.morris{at}wright.edu.


   Abstract
Angiotensin (Ang) AT1 receptors and Ang converting enzymes (ACE and ACE2) are expressed in the dorsal vagal complex (DVC) of the brainstem. The goal was to examine in vivo interactions between brainstem Ang AT1 receptors, ACE and ACE2 using shRNA gene silencing methods. The study takes advantage of the bilateral brainstem expression of renin angiotensin system (RAS) markers. Adenovirus vectors (Ad, 2.0x109 cfu/ml, 200nl) carrying interference small, hairpin RNA (shRNA) for either AngAT1a (Ad-AT1a-shRNA) or AngAT1b (Ad-AT1b-shRNA) were microinjected into the right side of the brainstem DVC. The Ad-LacZ control was injected into the left side. Brainstems were processed with in situ hybridization (ISH) and immunochemistry. Results showed: 1) Ad-AT1a-shRNA down-regulated Ang AT1a mRNA by 61.2 ± 6.8% (p<0.01). Ad-AT1b-shRNA down-regulated Ang AT1b mRNA by 51.6 ± 5.2% (p<0.01); 2) Down regulation of Ang AT1a mRNA was associated with decreased ACE2 mRNA expression (decrease of 29.0 ± 14.5 %, p<0.01) while reduction in Ang Ad-AT1b had no effect; 3) ACE mRNA expression was not altered by either RNAi treatment; 4) Immunochemical staining for Ang AT1 receptors, ACE and ACE2 were in agreement with the mRNA changes observed. These results demonstrate the utility of in vivo gene silencing to examine functional specificity. Ad-AT1a-shRNA and Ad-AT1b-shRNA induced site and subtype specific down-regulation of receptor expression. Gene silencing showed that there were interactions between brainstem Ang AT1a receptors and the RAS regulatory enzyme, ACE2.

Key Words: Cardiovascular, Medulla oblongata, Peptide




This article has been cited by other articles:


Home page
Exp PhysiolHome page
M. K. Raizada and J. F. R. Paton
Recent advances in the renin-angiotensin system: angiotensin-converting enzyme 2 and (pro)renin receptor
Exp Physiol, May 1, 2008; 93(5): 517 - 518.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the The Physiological Society.